ATXA Therapeutics to Participate in Bio€quity Europe 2023
ATXA Therapeutics will be attending the 23rd Bio€quity Europe Conference, due to be held from May 14 – 16, 2023, in Dublin’s Convention...
ATXA Therapeutics to Participate in Bio€quity Europe 2023
ATXA to Present at ATS International Conference 2023
NTP42 Demonstrates Key Cardioprotective Benefits in Newly-published Preclinical Findings
ATXA Therapeutics receives Funding through the European Innovation Council Accelerator Programme
ATXA Presentation at ERS International Congress 2022
European Commission publish article on ATXA's PAH-HOPE project
ATXA Presentation at ESC Congress 2021
Newly-published preclinical findings for ATXA Therapeutics' NTP42
World Orphan Drug Virtual Conference
Jonathan Langley Appointment
ATXA Therapeutics looks to raise $30m to secure regulatory approval